ESG Data

Promoting Environmental Management

Environment

Aspect Classification Items Scope Unit FY2013 FY2014 FY2015
CO2 Breakdown of CO2 emissions Sales vehicles In Japan t-CO2 7,433 7,016 6,809
Global t-CO2 35,058 30,635 28,012
Offices In Japan t-CO2 6,274 7,309 7,471
Global t-CO2 16,449 17,495 12,558
Plants and R&D centers In Japan t-CO2 160,086 164,186 161,877
Global t-CO2 488,135 427,166 202,832
Total In Japan t-CO2 173,793 178,511 176,157
Global t-CO2 539,642 475,296 243,402
CO2 emissions by Greenhouse Gas Protocol Scope 1 In Japan t-CO2 96,599 89,743 85,045
Global t-CO2 206,757 171,580 115,243
Scope 2 In Japan t-CO2 77,194 88,767 91,112
Global t-CO2 332,885 303,716 128,159
Scope 3 In Japan t-CO2 - 635,434 621,701
Energy Breakdown of energy use (in Japan) Electricity In Japan 1,000 GJ 1,850 1,803 1,821
City gas In Japan 1,000 GJ 1,642 1,527 1,493
Others (LPG, LNG heavy oil, kerosene, diesel, gasoline) In Japan 1,000 GJ 282 255 185
Steam In Japan 1,000 GJ 31 25 0
Total In Japan 1,000 GJ 3,806 3,610 3,499
Breakdown of energy use (Group overall) Electricity Global 1,000 GJ 4,937 2,370 2,439
City gas Global 1,000 GJ 1,827 1,710 1,656
Others (LPG, LNG heavy oil, kerosene, diesel, gasoline) Global 1,000 GJ 2,083 692 569
Total Global 1,000 GJ 8,847 4,772 4,664
Water resources Water used In Japan 1,000m3 11,628 11,624 11,868
Global 1,000m3 13,785 12,140 12,531
Wastewater In Japan 1,000m3 10,457 10,490 10,834
Global 1,000m3 11,615 10,937 11,288
Effective water usage volume*1 Global 1,000m3 - - 1,243
Water pollution BOD In Japan t 31 27 16
Global t 57 59 56
COD In Japan t 22 29 16
Global t 78 107 93
Waste Waste generated In Japan t 35,925 24,120 19,676
Global t 37,191 22,359 21,764
Outsourced waste treatment In Japan t 23,412 16,250 15,675
Global t 27,870 17,975 17,763
Recycled waste In Japan t 12,324 8,625 5,955
Global t 12,946 9,487 7,177
Recycling rates In Japan % 52.6 53.1 38.0
Final disposal volume In Japan t 165 143 91
Global t 1,486 913 853
Final disposal rate In Japan % 0.47 0.68 0.46
Amount of office paper consumed In Japan 10,000 pieces 6,717 5,898 5,469
Air Sox In Japan t 1.1 0.9 1.0
Global t 388 1.1 0.8
Nox In Japan t 43 59 45
Global t 232 66 51
PRTR Amount handled   In Japan t 6,248.8 2,726.3 3,686.1
Amount discharged (air) In Japan t 108.5 37.0 83.4
Amount discharged (water) In Japan t 4.4 3.8 0.0
Amount discharged (sewer) In Japan t 47.7 22.8 119.7
Amount discharged (waste) In Japan t 1.958.0 593.8 667.3
Containers Containers and packaging Required recycling volume In Japan t 2,222 2,263 2,039
Management ISO14001–certified sites In Japan Sites 7 7 6
Global Sites 15 8 7
Biodiversity Ecological Footprint   In Japan gha - 312,018 301,780

Social

Aspect Classification Items Scope Unit FY2013 FY2014 FY2015
Compliance Compliance training Total In Japan Persons 347 384 354
  Training new hires In Japan Persons 97 138 137
  Training newly appointed managerial employees In Japan Persons 185 168 109
  Training newly appointed executive candidates In Japan Persons 37 72 90
  Training mid-career hires In Japan Persons 28 6 18
Training on Daiichi Sankyo Group Individual Conduct Principles Ratio of employees participating in e-learning and group training In Japan % - - 100
Outside Japan % - - 100
Training related to the Promotion Code Ratio of employees participating in e-learning and group training In Japan % 100 100 100
Compliance violations discovered through DS‒hotline and reporting venues for sexual and power harassment In Japan Cases 5 6 7
Compliance training based on U.S. CIA*2 In Japan Persons - 74 37
Outside Japan Persons - 1,094 772
Training by UN Global
Compact area (human rights)
Views of intranet
training pages (aggregate)
In Japan Times - - 1,578
GVP training Ratio of GVP-related employees undergoing training Non‒
consolidated
% - 100 100
Ratio of all employees (excluding GVP-related employees) undergoing training Non‒
consolidated
% - 98.4 98.6
Development-related training (including GCP) Aggregate number of e-learning programs and group training sessions Non‒
consolidated
Times 27 24 31
CSR-related surveys for business partners Response rate (number of companies responding to surveys / number of raw material-related business partners) In Japan % - - 83%
Compliance awareness surveys Response rate In Japan % - 85 -
Rate of newly employed MRs passing certificate test Test pass rate In Japan % 100 100 100
Number of recalls (Class I
*3)
Number of recalls Global Cases 0 0 0

Mutual Growth of Employees and the Company

Aspect Classification Items Scope Unit FY2013 FY2014 FY2015
Employees Number of employees by region*4 In Japan In Japan Persons 9,145 8,549 8,589
Outside JapanTotal Outside Japan Persons 8,111 7,879 6,660
  Asia Outside Japan Persons - - 1,888
  South and Central America Outside Japan Persons - - 454
  US Outside Japan Persons - - 2,321
  Europe Outside Japan Persons - - 1,997
Ranbaxy Group Outside Japan Persons 15,535 - -
Total Consolidated Persons 32,791 16,428 15,249
Employee data*4 Number of men employees In Japan Persons 7,170 6,788 6,631
Outside Japan Persons - - 3,290
Number of women employees In Japan Persons 2,157 1,973 1,958
Outside Japan Persons - - 3,370
Average years of service In Japan Years 17.8 18.0 17.6
Percentage of women employees In Japan % 22.6 22.1 22.8
Global % - - 34.9
Percentage of women in managerial positions In Japan % 4.2 4.5 5.0
Global % - - 20.5
Ratio of newly appointed female managers In Japan % 9.6 9.2 13.1
Challenged worker*4 Employment rate of people with physical or mental disabilities In Japan % 2.21 2.34 2.45
Human resource development Number of company‒wide award winners*5 In Japan Persons 51 46 49
Aggregate amount of rank-based training time In Japan Hours 17,813 17,678 23,254
Aggregate voluntary training time In Japan Hours 2,280 2,700 4,875
Employee turnover ratio In Japan   1.2 1.0 0.9
Persons taking childcare leave Women taking child care leave In Japan Persons 155 133 124
Men taking child care leave In Japan Persons 2 12 7
Occupational health and safety management Paid vacation usage rate In Japan % 56.1 65.4 60.1
Total annual hours worked In Japan Times 1,868 1,840 1,834
Frequency In Japan*6 - 0.65 0.27 0.46
Outside Japan*7 - - - 6.264
Accident severity rate In Japan*6 - 0.002 0.002 0.002
Outside Japan*7 - - - 0.1
Training by area described in the UN Global Compact (labour) Views of intranet training pages (aggregate) In Japan Times - - 1,137
Labor Union Percentage/rate of participation in a labor union In Japan % 100 100 100
Global % - - 75.2

Enhancement of Communication with Stakeholders

Aspect Classification Items Scope Unit FY2013 FY2014 FY2015
Patients and medical professionals Evaluation of corporate stance and MR activities MRs rated (all responding physicians)*8 In Japan Rank First First First
Overall assessment of MRs (cardiologists)*8 In Japan Rank First First First
Number of inquiries received (pharmaceutical products)   In Japan Cases 120,000 120,000 118,000
Shareholders Dividends per share Interim Non‒
consolidated
Yen 30 30 40
Year–end Non‒
consolidated
Yen 30 30 30
Total Non‒
consolidated
Yen 60 60 70

Improving Access to Healthcare

Aspect Classification Items Scope Unit FY2013 FY2014 FY2015
Social Number of mobile healthcare field clinics Number of activities In India Times 501 499 503
In Cameroon Times 1,141 1,773 1,758
In Tanzania Times 202 306 408
IMCI*9training Number of training recipients In China   - - 190
Number of development projects conducted through the GHIT Fund*10       3 3 3

Social Contribution Activities

Aspect Classification Items Scope Unit FY2013 FY2014 FY2015
Social Amount of contributions   In Japan ¥ Million 2,780 2,549 2,176
Number of visitors to our factories   In Japan Persons 1,600 1,700 1,200
Number of visitors to Kusuri Museum   Non‒
consolidated
Persons 11,811 14,695 13,674
Employees Acquisition of volunteer leave   In Japan Persons 16 20 15
Number of employees receiving leave for volunteer activities   In Japan Persons 0 0 0
Number of employees receiving leave for marrow donation   In Japan Persons 1 3 3

Governance

Aspect Classification Items Scope Unit FY2013 FY2014 FY2015
Governance Structure of Board of Directors Number of directors Non‒
consolidated
Persons 10 10 10
Number of outside directors Non‒
consolidated
Persons 4 4 4
Number of woman directors Non‒
consolidated
Persons 0 0 0
Structure of Board of audit & supervisory boards Number of audit & supervisory boards Non‒
consolidated
Persons 4 4 4
Number of outside audit & supervisory boards Non‒
consolidated
Persons 2 2 2
Number of outside audit & supervisory boards (woman) Non‒
consolidated
Persons 0 1 1
Remuneration of directors Total Non‒
consolidated
¥ Million 669 555 612
Remuneration of audit &supervisory boards Total Non‒
consolidated
¥ Million 105 105 105
Composition of Compensation Committee Ratio of independent directors / auditors Non‒
consolidated
% 100 100 100
Composition of Nomination Committee Ratio of independent directors / auditors Non‒
consolidated
% 100 100 100

*1 Water intake-Wastewater

*2 Corporate Integrity Agreement: an agreement regarding legal compliance

*3 A situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

*4 Figures as of the settlement date of each Group company; numbers of employees (in Japan) except fiscal 2015 are as of April 1 of the following fiscal year; figures for employment rate of people with physical or mental disabilities are as of June 1 for all fiscal years except fiscal 2015

*5 The total number of employees who received prize from the culture-building and achievement awards.

*6 Scope of data: DAIICHI SANKYO COMPANY, LIMITED, Daiichi Sankyo Espha Co., Ltd., Daiichi Sankyo Healthcare Co., Ltd., Daiichi Sankyo Propharma Co., Ltd., Daiichi Sankyo Chemical Pharma Co., Ltd., Daiichi Sankyo Logistics Co., Ltd., Asubio Pharma Co., Ltd., Daiichi Sankyo RD Novare Co., Ltd., Daiichi Sankyo Business Associe Co., Ltd.

*7 Scope of data: Luitpold Pharmaceuticals, Inc., Daiichi Sankyo Europe GmbH (Pfaffenhofen Plant), Daiichi Sankyo Europe GmbH, Daiichi Sankyo (China) Holdings Co., Ltd., Daiichi Sankyo Pharmaceutical (Beijing) Co., Ltd., Daiichi Sankyo Pharmaceutical (Shanghai) Co., Ltd., Daiichi Sankyo Hong Kong Ltd., Daiichi Sankyo Korea Co., Ltd., Daiichi Sankyo Taiwan Ltd., Daiichi Sankyo Brasil Farmaceutica LTDA.

*8 Conducted by ANTERIO Inc.(FY2013-FY2015)

*9 Integrated Management of Childhood Illness Strategy

*10 Global Health Innovative Technology Fund

pdf iconIn order to view the PDF files, you need to install latest version Adobe Reader